Real-World Experience of Fluocinolone Acetonide (0.2 Μg/Day) Intravitreal Implant in the Treatment of Diabetic Macular Oedema

European Ophthalmic Review
doi 10.17925/eor.2015.09.01.42
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Touch Medical Media, Ltd.

Related search

The USER Study: A Chart Review of Patients Receiving a 0.2 Μg/Day Fluocinolone Acetonide Implant for Diabetic Macular Edema

Ophthalmology and Therapy
Ophthalmology
2018English

Fluocinolone Acetonide (0.19 Mg) Intravitreal Implant Reduces Treatment Burden and Improves Practice Resource Utilisation for Patients With Diabetic Macular Oedema

BMJ Open Ophthalmology
Ophthalmology
2020English

Fluocinolone Acetonide Intravitreal Implant (Retisert® ) in the Treatment of Sight Threatening Macular Oedema of Juvenile Idiopathic Arthritis-Related Uveitis

Acta Ophthalmologica
MedicineOphthalmology
2018English

Clinical Evaluation of Intravitreal Triamcinolone Acetonide in Diabetic Macular Oedema

Scholars Journal of Applied Medical Sciences
2016English

Clinical Effectiveness of Intravitreal Fluocinolone Acetonide (FAc) (ILUVIEN™) in Patients With Diabetic Macular Oedema (DMO) Refractory to Prior Therapy: The Manchester Experience

Ophthalmology and Therapy
Ophthalmology
2019English

Outcomes in Diabetic Macular Edema Switched Directly or After a Dexamethasone Implant to a Fluocinolone Acetonide Intravitreal Implant Following Anti-Vegf Treatment

Acta Diabetologica
Internal MedicineMedicineDiabetesMetabolismEndocrinology
2019English

Efficacy and Safety of Corticosteroid Implant (Fluocinolone Acetonide (FAc) 0.2 Μ G/Day, Iluvien ® ) for Management of Diabetic Macular Edema (DME): A Real‐life Study

Acta Ophthalmologica
MedicineOphthalmology
2018English

Accidental Intralenticular Injection of Dexametasone Intravitreal Implant During the Treatment of Refractory Diabetic Macular Oedema

Oftalmologicheskii Zhurnal
Ophthalmology
2018English

Efficacy and Safety of Sustained-Delivery Fluocinolone Acetonide Intravitreal Implant in Patients With Chronic Diabetic Macular Edema Insufficiently Responsive to Available Therapies: A Real-Life Study

Clinical Ophthalmology
Ophthalmology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy